Related references
Note: Only part of the references are listed.Mechanism of spliceosome remodeling by the ATPase/helicase Prp2 and its coactivator Spp2
Rui Bai et al.
SCIENCE (2021)
Oxidative phosphorylation as a potential therapeutic target for cancer therapy
Valentina Sica et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
Pembrolizumab for advanced anal squamous cell carcinoma (ASCC): Results from the multicohort, phase II KEYNOTE-158 study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Molecular and cellular intratumoral heterogeneity in primary glioblastoma: clinical and translational implications
Joshua D. Bernstock et al.
JOURNAL OF NEUROSURGERY (2020)
A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity
Fadi Jacob et al.
CELL (2020)
Genomic and Phenotypic Characterization of a Broad Panel of Patient-Derived Xenografts Reflects the Diversity of Glioblastoma
Rachael A. Vaubel et al.
CLINICAL CANCER RESEARCH (2020)
Longitudinal assessment of tumor development using cancer avatars derived from genetically engineered pluripotent stem cells
Tomoyuki Koga et al.
NATURE COMMUNICATIONS (2020)
Proneural and mesenchymal glioma stem cells display major differences in splicing and lncRNA profiles
Gabriela D. A. Guardia et al.
NPJ GENOMIC MEDICINE (2020)
Tackling the Many Facets of Glioblastoma Heterogeneity
Itay Tirosh et al.
CELL STEM CELL (2020)
Therapeutic modulation of phagocytosis in glioblastoma can activate both innate and adaptive antitumour immunity
Christina A. von Roemeling et al.
NATURE COMMUNICATIONS (2020)
The powerful world of antisense oligonucleotides: From bench to bedside
Anais M. Quemener et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2020)
The Emerging Role of Myeloid-Derived Suppressor Cells in the Glioma Immune Suppressive Microenvironment
Yajing Mi et al.
FRONTIERS IN IMMUNOLOGY (2020)
Effect of Nivolumab vs Bevacizumab in Patients With Recurrent Glioblastoma The CheckMate 143 Phase 3 Randomized Clinical Trial
David A. Reardon et al.
JAMA ONCOLOGY (2020)
Mechanisms and therapeutic implications of hypermutation in gliomas
Mehdi Touat et al.
NATURE (2020)
Radiation Induced Metabolic Alterations Associate With Tumor Aggressiveness and Poor Outcome in Glioblastoma
Kshama Gupta et al.
FRONTIERS IN ONCOLOGY (2020)
Roles and mechanisms of alternative splicing in cancer - implications for care
Sophie C. Bonnal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Differential roles of pyramidal and fast-spiking, GABAergic neurons in the control of glioma cell proliferation
Elena Tantillo et al.
NEUROBIOLOGY OF DISEASE (2020)
Purine metabolism regulates DNA repair and therapy resistance in glioblastoma
Weihua Zhou et al.
NATURE COMMUNICATIONS (2020)
Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas
Faiqa Mudassar et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)
Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells
Seamus Caragher et al.
CANCERS (2020)
Dichloroacetate Radiosensitizes Hypoxic Breast Cancer Cells
Sven de Mey et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Spliceosome Mutations in Uveal Melanoma
Josephine Q. N. Nguyen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study
Aurelien Marabelle et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma
Jiayi Huang et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma
Junfei Zhao et al.
NATURE MEDICINE (2019)
Challenges to curing primary brain tumours
Kenneth Aldape et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
The lncRNA TP73-AS1 is linked to aggressiveness in glioblastoma and promotes temozolomide resistance in glioblastoma cancer stem cells
Gal Mazor et al.
CELL DEATH & DISEASE (2019)
Modeling Patient-Derived Glioblastoma with Cerebral Organoids
Amanda Linkous et al.
CELL REPORTS (2019)
Temozolomide Induced Hypermutation in Glioma: Evolutionary Mechanisms and Therapeutic Opportunities
Paul Daniel et al.
FRONTIERS IN ONCOLOGY (2019)
Glioblastoma heterogeneity and the tumour microenvironment: implications for preclinical research and development of new treatments
Sally L. Perrin et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2019)
Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39
Maisa C. Takenaka et al.
NATURE NEUROSCIENCE (2019)
An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma
Cyril Neftel et al.
CELL (2019)
Mechanisms of immunotherapy resistance: lessons from glioblastoma
Christopher M. Jackson et al.
NATURE IMMUNOLOGY (2019)
SRSF3-Regulated RNA Alternative Splicing Promotes Glioblastoma Tumorigenicity by Affecting Multiple Cellular Processes
Xiao Song et al.
CANCER RESEARCH (2019)
Estrogen-related receptor β activation and isoform shifting by cdc2-like kinase inhibition restricts migration and intracranial tumor growth in glioblastoma
Deanna M. Tiek et al.
FASEB JOURNAL (2019)
Electrical and synaptic integration of glioma into neural circuits
Humsa S. Venkatesh et al.
NATURE (2019)
Synaptic proximity enables NMDAR signalling to promote brain metastasis
Qiqun Zeng et al.
NATURE (2019)
The Phenotypes of Proliferating Glioblastoma Cells Reside on a Single Axis of Variation
Lin Wang et al.
CANCER DISCOVERY (2019)
Longitudinal molecular trajectories of diffuse glioma in adults
Floris P. Barthel et al.
NATURE (2019)
GENE-49. RNA PROCESSING GENES CHARACTERIZE RNA SPLICING AND FURTHER STRATIFY LOWER-GRADE GLIOMA
Rui-Chao Chai et al.
NEURO-ONCOLOGY (2019)
Role of alternative splicing signatures in the prognosis of glioblastoma
Zu-cheng Xie et al.
CANCER MEDICINE (2019)
Mutations in Splicing Factor Genes in Myeloid Malignancies: Significance and Impact on Clinical Features
Valeria Visconte et al.
CANCERS (2019)
Splicing factor SRSF1 promotes gliomagenesis via oncogenic splice-switching of MYO1B
Xuexia Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
PI3K/Akt signaling transduction pathway, erythropoiesis and glycolysis in hypoxia
Youbang Xie et al.
MOLECULAR MEDICINE REPORTS (2019)
Hypoxia Imaging and Adaptive Radiotherapy: A State-of-the-Art Approach in the Management of Glioma
Michael Gerard et al.
FRONTIERS IN MEDICINE (2019)
Nivolumab with or without ipilimumab in patients with recurrent glioblastoma: results from exploratory phase I cohorts of CheckMate 143
Antonio Omuro et al.
NEURO-ONCOLOGY (2018)
The pro-tumorigenic effects of metabolic alterations in glioblastoma including brain tumor initiating cells
Catherine J. Landis et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2018)
Targeting tumour hypoxia: shifting focus from oxygen supply to demand
James T. Coates et al.
BRITISH JOURNAL OF RADIOLOGY (2018)
Apoptotic Cell-Derived Extracellular Vesicles Promote Malignancy of Glioblastoma Via Intercellular Transfer of Splicing Factors
Marat S. Pavlyukov et al.
CANCER CELL (2018)
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
Hirokazu Sadahiro et al.
CANCER RESEARCH (2018)
Structure of the human activated spliceosome in three conformational states
Xiaofeng Zhang et al.
CELL RESEARCH (2018)
Current state and future prospects of immunotherapy for glioma
Neha Kamran et al.
IMMUNOTHERAPY (2018)
Tapping the RNA world for therapeutics
Judy Lieberman
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Tapping the RNA world for therapeutics
Judy Lieberman
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2018)
Alterations in Cell Motility, Proliferation, and Metabolism in Novel Models of Acquired Temozolomide Resistant Glioblastoma
D. M. Tiek et al.
SCIENTIFIC REPORTS (2018)
Immune Microenvironment in Glioblastoma Subtypes
Zhihong Chen et al.
FRONTIERS IN IMMUNOLOGY (2018)
Hypoxia-Inducible Factor-1α Activity as a Switch for Glioblastoma Responsiveness to Temozolomide
Alessia Lo Dico et al.
FRONTIERS IN ONCOLOGY (2018)
Transaminase Inhibition by 2-Hydroxyglutarate Impairs Glutamate Biosynthesis and Redox Homeostasis in Glioma
Samuel K. McBrayer et al.
CELL (2018)
Emerging roles of Myc in stem cell biology and novel tumor therapies
Go J. Yoshida
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
A novel enhancer regulates MGMT expression and promotes temozolomide resistance in glioblastoma
Xiaoyue Chen et al.
NATURE COMMUNICATIONS (2018)
The Cancer Spliceome: Reprograming of Alternative Splicing in Cancer
Ettaib El Marabti et al.
FRONTIERS IN MOLECULAR BIOSCIENCES (2018)
Advances in the molecular genetics of gliomas - implications for classification and therapy
Guido Reifenberger et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Analysis of temozolomide resistance in low-grade gliomas using a mechanistic mathematical model
Edouard Ollier et al.
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2017)
RNA processing as an alternative route to attack glioblastoma
Fabiana Marcelino Meliso et al.
HUMAN GENETICS (2017)
Treatment outcome of patients with recurrent glioblastoma multiforme: a retrospective multicenter analysis
Myra E. van Linde et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller et al.
LANCET ONCOLOGY (2017)
Patient-derived xenografts undergo mouse-specific tumor evolution
Uri Ben-David et al.
NATURE GENETICS (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Alternative splicing as a regulator of development and tissue identity
Francisco E. Baralle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma
James R. Perry et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Metformin and temozolomide, a synergic option to overcome resistance in glioblastoma multiforme models
Silvia Valtorta et al.
ONCOTARGET (2017)
Environmental stimuli shape microglial plasticity in glioma
Stefano Garofalo et al.
ELIFE (2017)
Polymeric nanoparticles promote macrophage reversal from M2 to M1 phenotypes in the tumor microenvironment
Yi Wang et al.
BIOMATERIALS (2017)
Single-cell profiling of human gliomas reveals macrophage ontogeny as a basis for regional differences in macrophage activation in the tumor microenvironment
Soren Muller et al.
GENOME BIOLOGY (2017)
Coordinated Splicing of Regulatory Detained Introns within Oncogenic Transcripts Creates an Exploitable Vulnerability in Malignant Glioma
Christian J. Braun et al.
CANCER CELL (2017)
O2•- and H2O2-Mediated Disruption of Fe Metabolism Causes the Differential Susceptibility of NSCLC and GBM Cancer Cells to Pharmacological Ascorbate (vol 31, pg 487, 2017)
Joshua D. Schoenfeld et al.
CANCER CELL (2017)
Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment
Qianghu Wang et al.
CANCER CELL (2017)
Intratumoral heterogeneity: pathways to treatment resistance and relapse in human glioblastoma
M. A. Qazi et al.
ANNALS OF ONCOLOGY (2017)
Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma
Zhihong Chen et al.
CANCER RESEARCH (2017)
Orally administered colony stimulating factor 1 receptor inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium phase II study
Nicholas Butowski et al.
NEURO-ONCOLOGY (2016)
Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
Roger M. Phillips
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2016)
A Three-Dimensional Organoid Culture System Derived from Human Glioblastomas Recapitulates the Hypoxic Gradients and Cancer Stem Cell Heterogeneity of Tumors Found In Vivo
Christopher G. Hubert et al.
CANCER RESEARCH (2016)
Relapsed Glioblastoma: Treatment Strategies for Initial and Subsequent Recurrences
Alicia Tosoni et al.
CURRENT TREATMENT OPTIONS IN ONCOLOGY (2016)
Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis
Daichi Inoue et al.
GENES & DEVELOPMENT (2016)
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
Eric Bouffet et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Clonal evolution of glioblastoma under therapy
Jiguang Wang et al.
NATURE GENETICS (2016)
Therapeutic targeting of splicing in cancer
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
Rescuing defective tumor-infiltrating T-cell proliferation in glioblastoma patients
Song Han et al.
ONCOLOGY LETTERS (2016)
Temozolomide in combination with metformin act synergistically to inhibit proliferation and expansion of glioma stem-like cells
Zhiyun Yu et al.
ONCOLOGY LETTERS (2016)
The anti-malarial atovaquone increases radiosensitivity by alleviating tumour hypoxia
Thomas M. Ashton et al.
NATURE COMMUNICATIONS (2016)
Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
Shohei Koyama et al.
NATURE COMMUNICATIONS (2016)
Management of glioblastoma after recurrence: A changing paradigm
Supriya Mallick et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2016)
Temozolomide resistance in glioblastoma multiforme
Sang Y. Lee
GENES & DISEASES (2016)
Functional genomics analyses of RNA-binding proteins reveal the splicing regulator SNRPB as an oncogenic candidate in glioblastoma
Bruna R. Correa et al.
GENOME BIOLOGY (2016)
Molecular Pathways in Gliomagenesis and Their Relevance to Neuropathologic Diagnosis
Christina L. Appin et al.
ADVANCES IN ANATOMIC PATHOLOGY (2015)
Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution
Hoon Kim et al.
GENOME RESEARCH (2015)
Randomized phase 2 study of carboplatin and bevacizumab in recurrent glioblastoma
Kathryn M. Field et al.
NEURO-ONCOLOGY (2015)
Sensitization of Glioblastoma Cells to Irradiation by Modulating the Glucose Metabolism
W. Christopher Newman et al.
NEUROSURGERY (2015)
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
D. T. Le et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
Jihye Yun et al.
SCIENCE (2015)
Immunosuppressive mechanisms of malignant gliomas: parallels at non-CNS sites
Powell Perng et al.
FRONTIERS IN ONCOLOGY (2015)
Durable Therapeutic Efficacy Utilizing Combinatorial Blockade against IDO, CTLA-4, and PD-L1 in Mice with Brain Tumors
Derek A. Wainwright et al.
CLINICAL CANCER RESEARCH (2014)
Radiosensitisation by pharmacological ascorbate in glioblastoma multiforme cells, human glial cells, and HUVECs depends on their antioxidant and DNA repair capabilities and is not cancer specific
M. Leticia Castro et al.
FREE RADICAL BIOLOGY AND MEDICINE (2014)
SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma
Julien Hadoux et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
A day in the life of the spliceosome
A. Gregory Matera et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2014)
Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma
Brett E. Johnson et al.
SCIENCE (2014)
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Anoop P. Patel et al.
SCIENCE (2014)
High-Dose Parenteral Ascorbate Enhanced Chemosensitivity of Ovarian Cancer and Reduced Toxicity of Chemotherapy
Yan Ma et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Patterns of relapse in glioblastoma multiforme following concomitant chemoradiotherapy with temozolomide
J. Sherriff et al.
BRITISH JOURNAL OF RADIOLOGY (2013)
EGFR Mutation-Induced Alternative Splicing of Max Contributes to Growth of Glycolytic Tumors in Brain Cancer
Ivan Babic et al.
CELL METABOLISM (2013)
Reprogramming Metabolism with Metformin Improves Tumor Oxygenation and Radiotherapy Response
Vanessa E. Zannella et al.
CLINICAL CANCER RESEARCH (2013)
Genome-wide RNAi screens in human brain tumor isolates reveal a novel viability requirement for PHF5A
Christopher G. Hubert et al.
GENES & DEVELOPMENT (2013)
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
Dennis Lindau et al.
IMMUNOLOGY (2013)
Anti-PD-1 Blockade and Stereotactic Radiation Produce Long-Term Survival in Mice With Intracranial Gliomas
Jing Zeng et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
Identifying the mesenchymal molecular subtype of glioblastoma using quantitative volumetric analysis of anatomic magnetic resonance images
Kourosh M. Naeini et al.
NEURO-ONCOLOGY (2013)
Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics
Andrea Sottoriva et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
DNA Base Damage by Reactive Oxygen Species, Oxidizing Agents, and UV Radiation
Jean Cadet et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2013)
Inhibition of Histone Deacetylation Potentiates the Evolution of Acquired Temozolomide Resistance Linked to MGMT Upregulation in Glioblastoma Xenografts
Gaspar J. Kitange et al.
CLINICAL CANCER RESEARCH (2012)
A SDHB malignant paraganglioma with dramatic response to temozolomide-capecitabine
Cecile Nozieres et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
The brain tumor microenvironment (vol 59, pg 1169, 2011)
Nikki A. Charles et al.
GLIA (2012)
Effects of hypoxia and HIFs on cancer metabolism
Vera Mucaj et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2012)
A phase II study of O6-benzylguanine and temozolomide in pediatric patients with recurrent or progressive high-grade gliomas and brainstem gliomas: a Pediatric Brain Tumor Consortium study
Katherine E. Warren et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Tumor cycling hypoxia induces chemoresistance in glioblastoma multiforme by upregulating the expression and function of ABCB1
Chii-Wen Chou et al.
NEURO-ONCOLOGY (2012)
Increased Microglia/Macrophage Gene Expression in a Subset of Adult and Pediatric Astrocytomas
Jane R. Engler et al.
PLOS ONE (2012)
Metabolic reprogramming in cancer: Unraveling the role of glutamine in tumorigenesis
Dania Daye et al.
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2012)
Temozolomide: Mechanisms of Action, Repair and Resistance
Jihong Zhang et al.
Current Molecular Pharmacology (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Mechanisms of Ascorbate-Induced Cytotoxicity in Pancreatic Cancer
Juan Du et al.
CLINICAL CANCER RESEARCH (2010)
Acquisition of Temozolomide Chemoresistance in Gliomas Leads to Remodeling of Mitochondrial Electron Transport Chain
Claudia R. Oliva et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Metabolic Modulation of Glioblastoma with Dichloroacetate
E. D. Michelakis et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Phase II Trial of Temozolomide Plus O6-Benzylguanine in Adults With Recurrent, Temozolomide-Resistant Malignant Glioma
Jennifer A. Quinn et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial
Roger Stupp et al.
LANCET ONCOLOGY (2009)
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Matthew G. Vander Heiden et al.
SCIENCE (2009)
Hypoxia and cancer
M. Christiane Brahimi-Horn et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Hypoxia-inducible factor I and dysregulated c-myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1
Jung-Whan Kim et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Mechanisms operative in the antitumor activity of temozolomide in glioblastoma multiforme
Tamar Fisher et al.
CANCER JOURNAL (2007)
Loss of the mismatch repair protein MSH6 in human glioblastomas is associated with tumor progression during temozolomide treatment
Daniel P. Cahill et al.
CLINICAL CANCER RESEARCH (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Radiotherapy and temozolomide for newly diagnosed glioblastoma: Recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial
RO Mirimanoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines
Jeongwu Lee et al.
CANCER CELL (2006)
A hypermutation phenotype and somatic MSH6 mutations in recurrent human malignant gliomas after alkylator chemotherapy
C Hunter et al.
CANCER RESEARCH (2006)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Pladienolides, new substances from culture of Streptomyces platensis Mer-11107 III.: In vitro and In vivo antitumor activities
Y Mizui et al.
JOURNAL OF ANTIBIOTICS (2004)
Share Paper
